DAFTAR PUSTAKA
1. Antunes C, Aleem A, Curtis SA. Gastroesophageal reflux disease [Internet].
2022 [cited 2022 Apr 24]. p. 1–25. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK441938/
2. PGI. Konsensus nasional penatalaksanaan penyakit Refluks Gastroesopageal (Gastroesophageal Reflux Diseases/GERD) di Indonesia (revisi 2019). Vol.
1. 2019. 3–36 p.
3. Danisa M. Clarrett M, Christi ne Hachem M. Gastroesophageal reflux disease (GERD). 2018;1:214–8.
4. Eusebi LH, Cirota GG, Zagari RM, Ford AC. Global prevalence of Barrett’s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: A systematic review and meta-analysis. Gut. 2021;70(3):456–63.
5. Dirac MA, Safiri S, Tsoi D, Adedoyin RA, Afshin A, Akhlaghi N, et al. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol.
2020;5(6):561–81.
6. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: A meta-analysis. Gut. 2018;67:430–40.
7. Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease. J Neurogastroenterol Motil. 2021;27(4):453–81.
8. Simarmata DO, Wahyudi Y, Bestari MB, Supriadi R. Relationship between Gastroesophageal Reflux Disease Questionnaire (GERD-Q) score and reflux oesophagitis in Gastroesophageal Reflux Disease (GERD) suspected patients in Bandung. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2020;20:154–60.
9. Syam AF, Abdullah M, Rani AA. Prevalence of reflux esophagitis, Barret’s esophagus and esophageal cancer in Indonesian people evaluation by endoscopy. Canc Res Treat. 2003;5:83.
10. Syam A, Cecep Suryani S, Puspita H, Murdani A, Makmun D. Prevalence and risk factors of GERD in Indonesian population—an internet-based study.
American Scientific Publishers. 2017;23:6734–8.
11. Pan J, Cen L, Chen W, Yu C, Li Y, Shen Z. Alcohol consumption and the risk of Gastroesophageal Reflux Disease: a systematic review and meta- analysis. Oxford, Oxfordshire. 2019;54:62–9.
12. Ness-Jensen E, Lagergren J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol.
2017;31:501–8.
13. Fujiwara Y, Uemura R. Gastroesophageal reflux diseases and lifestylefactors. Vol. 1, Alcoholic/Non-Alcoholic Digestive Diseases.
Springer Singapore; 2019. 13–21 p.
14. WHO. Obesity [Internet]. [cited 2022 Feb 26]. Available from:
https://www.who.int/health-topics/obesity#tab=tab_1
15. WHO. Obesity and overweight [Internet]. 2021 [cited 2022 Feb 28].
Available from: https://www.who.int/news-room/fact-sheets/detail/obesity- and-overweight
16. Badan Litbangkes. Riset kesehatan dasar(RISKESDAS) 2007. 2007;49–53.
17. Badan Litbangkes. Riset kesehatan dasar(RISKESDAS) 2018. 2018;582–9.
18. Feingold KR. Obesity and dyslipidemia. Endotext[internet], editor. Vol. 1.
MDText.com; 2020. 1–95 p.
19. Yi Lee, Waqas J. Siddiqui. Cholesterol levels. Vol. 1. 2022. 1–20 p.
20. NCEP. ATP III guidelines at-a-glance quick desk reference. National Institutes of HealthNational Heart, Lung, and Blood Institute. 2001;1:1–6.
21. Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport.
22. Nakano T, Inoue I, Murakoshi T. A newly integrated model for intestinal cholesterol absorption and efflux reappraises how plant sterol intake reduces circulating cholesterol levels. Nutrients 2019. 2019;11:310.
23. Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218.
24. Hsieh YH, Wu MF, Yang PY, Liao WC, Hsieh YH, Chang YJ, et al. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. BMC Gastroenterol. 2019;19:1–10.
25. Nomura M, Tashiro N, Watanabe T, Hirata A, Abe I, Okabe T, et al.
Association of symptoms of gastroesophageal reflux with metabolic syndrome parameters in patients with endocrine disease. ISRN Gastroenterol. 2014;1:1–6.
26. Sastroasmoro PS, Ghazali MV, Sastromihardjo S, Soedjarwo R. Dasar-dasar metodologi penelitian klinis. Vol. 5. Jakarta: Sagung Seto; 2014. 352–386 p.
27. Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Buku ajar ilmu penyakit dalam. Vol. 6. Fakultas Kedokteran Universitas Indonesia; 2014.
1748–1756 p.
28. Fahrial A, Chaidir S, Kaka A, Marcellus R, Murdani S, Tjahjadi A, et al.
Revisi konsensus nasional penatalaksanaan penyakit refluks gastroesofageal (Gastroesophageal Reflux Disease/GERD) di Indonesia. 2013. 2–20 p.
29. WGO. Gastroesophageal Reflux Disease. 2015;1:3–37.
30. WHO. Years of healthy life lost due to disability (YLD) [Internet]. [cited 2022 Mar 23]. Available from: https://www.who.int/data/gho/indicator- metadata-registry/imr-details/160
31. Tan PO, Soh AY sen, Kusano C, Lee YY, Gotoda T. Is There an increasing incidence of gastroesophageal junctional adenocarcinoma and Barrett esophagus in Asia? A review of diagnostic conundrums. Digestion.
2022;103:37–44.
32. P2PTM Kemenkes RI. Indeks massa tubuh [Internet]. 2018 [cited 2022 Mar
25]. Available from:
http://p2ptm.kemkes.go.id/preview/infografhic/bagaimana-cara- menghitung-imt-indeks-massa-tubuh
33. Elliott JA, Reynolds J v. Visceral obesity, metabolic syndrome, and esophageal adenocarcinoma. Front Oncol. 2021;11:692.
34. Šimunić M, Meštrović A. Obesity and gastroesophageal reflux disease.
Department of Gastroenterology and Hepatology, Internal Medicine Clinic, University Hospital Center Split. 2018;1:15–20.
35. Smith R, Shahjehan R. Hiatal hernia. Vol. 1. StatPearls Publishing LLC;
2022. 1–14 p.
36. Rohof WOA, Smout AJPM. Hiatus hernia and gastroesophageal reflux disease. The Esophagus. 2021;1:347–57.
37. Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet. Rocz Panstw Zakl Hig. 2021;72:21–8.
38. Saputera MD, Budianto W. Diagnosis dan tatalaksana Gastroesophageal Refeux Disease (GERD) di pusat pelayanan kesehatan primer. 2017;44:329–
32.
39. Bayupurnama P. Dispepsia & penyakit refluks gastroesofageal. 1st ed. Vol.
1. Jakarta: EGC; 2019. 1–128 p.
40. Endoscopy Campus - Reflux Esophagitis: Los Angeles Classification [Internet]. [cited 2022 Jun 11]. Available from: https://www.endoscopy- campus.com/en/classifications/reflux-esophagitis-los-angeles-
classification/
41. Murray R, Granner D, Rodwell V. Lipid yang penting secara fisiologis.
Biokimia Harper Jakarta: EGC. 2009;128–37.
42. Feingold KR. Introduction to lipids and lipoproteins. Vol. 1. 2020. 5–22 p.
43. Blaha MJ, Baron RB. Lipid disorders. In: Current medical diagnosis and
44. Enkhmaa B, Anuurad E, Berglund L. Lipoprotein: impact by ethnicity and environmental and medical conditions. J Lipid Res. 2016;57(7):1111–25.
45. Bergström H, Ekström L, Warnqvist A, Bergman P, Björkhem-Bergman L.
Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers. BMC Womens Health. 2021;21:1–
10.
46. Waage CW, Mdala I, Stigum H, Jenum AK, Birkeland KI, Shakeel N, et al.
Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity. BMC Pregnancy Childbirth. 2022;22:246.
47. Kim KB, Kim K, Kim C, Kang SJ, Kim HJ, Yoon S, et al. Effects of exercise on the body composition and lipid profile of individuals with obesity: a systematic review and meta-analysis. J Obes Metab Syndr. 2019;28:278.
48. Feingold KR, Brinton EA, Grunfeld C. The effect of endocrine disorders on lipids and lipoproteins. Vol. 1. 2020. 8–9 p.
49. Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front Endocrinol (Lausanne). 2018;9:511.
50. PB Perkeni. Pengelolaan dislipidemia di Indonesia 2019. Vol. 1. 2019. 5–8 p.
51. Rivera K, Quiñones V, Amigo L, Santander N, Salas-Pérez F, Xavier A, et al. Lipoprotein receptor SR-B1 deficiency enhances adipose tissue inflammation and reduces susceptibility to hepatic steatosis during diet- induced obesity in mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2021 Jun 1;1866(6):158909.
52. BPS. istilah usia produktif [Internet]. [cited 2022 Oct 7]. Available from:
https://www.bps.go.id/istilah/index.html?Istilah_page=4
53. Pemerintah Indonesia. UU Republik Indonesia nomor 20 tahun 2003 tentang sistem pendidikan nasional.
54. Klasifikasi Obesitas setelah pengukuran IMT - Direktorat P2PTM [Internet].
[cited 2023 Feb 9]. Available from: https://p2ptm.kemkes.go.id/infographic- p2ptm/obesitas/klasifikasi-obesitas-setelah-pengukuran-imt
55. Effendi S, Singarimbun M. Metode penelitian survai. 1995;2:101–4.
56. Khoerina A, Sofiyan E, Kurnia Ningsih D, Suerni T, Studi sarjana Keperawatan dan Profesi Ners P, Tinggi Ilmu Kesehatan Kendal S, et al.
Gambaran kecemasan masyarakat dalam berkunjung ke pelayanan kesehatan pada masa pandemi COVID-19.
57. Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of Gastroesophageal Reflux Disease: are patients getting younger? J Neurogastroenterol Motil [Internet]. 2018 Oct 1 [cited 2022 Dec 22];24(4):559. Available from: /pmc/articles/PMC6175565/
58. Mochizuki N, Fujita T, Kobayashi M, Yamazaki Y, Terao S, Sanuki T, et al.
Factors associated with the presentation of erosive esophagitis symptoms in health checkup subjects: A prospective, multicenter cohort study. PLoS One [Internet]. 2018 May 1 [cited 2023 Mar 3];13(5):e0196848. Available from:
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196848 59. ACG. Acid Reflux [Internet]. [cited 2022 Dec 23]. Available from:
https://gi.org/topics/acid-reflux/#:~:text=the%2Dcounter%20medicines.- ,Lifestyle%20Modifications,Weight%20loss%20if%20overweight.
60. Yuan LZ, Yi P, Wang GS, Tan SY, Huang GM, Qi LZ, et al. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China.
Therap Adv Gastroenterol. 2019;12.
61. Radjamin ISP, Nusi IA, Kalanjati VP. Profil penderita GERD dan NERD di RSUD. Dr. Soetomo Surabaya. 2019;29(1):1–6.
62. Lee ES, Kim N, Lee SH, Park YS, Kim JW, Jeong SH, et al. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Aliment Pharmacol
63. Nurleili RA, Purnamasari D, Simadibrata M, Rachman A, Tahapary DL, Gani RA. Visceral fat thickness of erosive and non-erosive reflux disease subjects in Indonesia’s tertiary referral hospital. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2019 May 1;13(3):1929–33.
64. Vazquez JC. Heartburn in pregnancy. BMJ Clin Evid [Internet]. 2015 Sep 8 [cited 2023 Jan 26];2015. Available from: /pmc/articles/PMC4562453/
65. Rathi P, Gill A, Vankar GK, Ohri N, Patel A, Resident J. Study of depression and anxiety in endoscopically diagnosed cases of Gastro-Oesophageal Reflux Disease (GERD). Indian Journal of Mental Health. 2018;5(3).
66. Jeong I du, Park MI, Kim SE, Kim BJ, Kim SW, Kim JH, et al. The degree of disease knowledge in patients with gastroesophageal reflux disease: A multi-center prospective study in Korea. J Neurogastroenterol Motil.
2017;23(3):385–91.
67. Alshaikh OM, Alkhonain IM, Anazi MS, Alahmari AA, Alsulami FO, Alsharqi AA. Assessing the degree of Gastroesophageal Reflux Disease (GERD) knowledge among the riyadh population. 2021 [cited 2023 Jan 27];
Available from: https://cran.r-
68. Samidah I, Samidah I, Sofais DAR, Suyanto J. Living condition, economic and stress among housewife during COVID-19 pandemic. Jurnal Aisyah : Jurnal Ilmu Kesehatan [Internet]. 2022 Feb 27 [cited 2023 Jan 27];7(1):303–
8. Available from:
https://aisyah.journalpress.id/index.php/jika/article/view/949
69. Wang HY, Balakumaran Leena K, Plymoth A, Hergens MP, Yin L, Trivikrama Shenoy K, et al. Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India. 2016;
70. Baeg MK, Ko SH, Ko SY, Jung HS, Choi MG. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: A large-scale cross-sectional study. BMC Gastroenterol. 2018 Jun 8;18(1).
71. Toki Y, Yamauchi R, Kayashima E, Adachi K, Kishi K, Suetsugu H, et al.
Predictive factors for future onset of reflux esophagitis: a longitudinal case-
control study using health checkup records. J Neurogastroenterol Motil.
2022 Jan 1;28(1):86–94.
72. de Bortoli N. Obesity is a risk factor for Erosive Gastroesophageal Reflux Disease: prospective case-control study. J Gastrointest Dig Syst.
2014;04(03).
73. Sfara A, Dumitrascu DL. The management of hiatal hernia: an update on diagnosis and treatment. Med Pharm Rep [Internet]. 2019 [cited 2023 Jan
23];92(4):321–5. Available from:
https://pubmed.ncbi.nlm.nih.gov/31750430/
74. Abdulrahman Alzahrani S, Zaki Alshaikhmohamed M, Mohammed Albalawi A, Mashni Alharbi N, Muneer Alqatari B, Ali Alatwi S, et al.
Gastroesophageal reflux disease and heartburn among the general population of Saudi Arabia. [cited 2023 Jan 23]; Available from:
https://doi.org/10.24911/IJMDC.51-1567426442
75. Didik Kuswono A, Yurizali B, Akbar RR. Kejadian Gastroesophageal Reflux Disease (GERD) dengan GERD-Q pada mahasiswa kedokteran.
BRMJ : Baiturrahmah Medical Journal Baiturrahmah Medical Journal.
76. Patala R, Tandi J, Ulzmi N, Fahruddin F. Rasionalitas penggunanaan obat pada pasien GERD di instalasi rawat inap Rumah Sakit Umum Anutapura Palu. JPSCR: Journal of Pharmaceutical Science and Clinical Research.
2021 Mar 17;6(1):62.
77. Katz PO. Ambulatory reflux monitoring in the patient with GERD [Internet].
[cited 2023 Jan 27]. Available from:
https://www.medscape.org/viewarticle/494196
78. Chua CS, Lin YM, Yu FC, Hsu YH, Chen JH, Yang KC, et al. Metabolic risk factors associated with erosive esophagitis. Journal of Gastroenterology and Hepatology (Australia). 2009;24(8):1375–9.
79. Wei TY, Hsueh PH, Wen SH, Chen CL, Wang CC. The role of tea and coffee in the development of gastroesophageal reflux disease. Tzu-Chi Medical
Journal [Internet]. 2019 Jul 1 [cited 2023 Jan 27];31(3):169. Available from:
/pmc/articles/PMC6559035/
80. Mohammadi M, Jolfaie NR, Alipour R, Zarrati M. Is metabolic syndrome considered to be a risk factor for gastroesophageal reflux disease (non- erosive or erosive esophagitis)?: A systematic review of the evidence. Iran Red Crescent Med J. 2016 Nov 1;18(11).
81. Matsuzaki J, Suzuki H, Iwasaki E, Yokoyama H, Sugino Y, Hibi T. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn. Neurogastroenterology and Motility. 2010 Sep;22(9).
82. Chung S, Parks JS. Dietary cholesterol effects on adipose tissue inflammation. 2016;27(1):19–25.
83. Fujikawa Y, Tominaga K, Fujii H, MacHida H, Okazaki H, Yamagami H, et al. High prevalence of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. Digestion. 2012 Oct;86(3):228–37.
84. Mocanu MA, Diculescu M, Dumitrescu M. Internal medicine-pediatrics gastroesophageal reflux and metabolic syndrome. Vol. 117, Rev. Med. Chir.
Soc. Med. Nat. 2013.
85. IFFGD. Motility disorders [Internet]. [cited 2023 Feb 1]. Available from:
https://iffgd.org/gi-disorders/motility-disorders/
86. Kumar S, Sharma S, Norboo T, Dolma D, Norboo A, Stobdan T, et al.
Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area. Indian Journal of Gastroenterology. 2011 May;30(3):135–43.
87. Kallel L, Bibani N, Fekih M, Matri S, Karoui S, Mustapha NB, et al.
Metabolic syndrome is associated with gastroesophageal reflux disease based on a 24-hour ambulatory pH monitoring. Diseases of the Esophagus.
2011 Apr;24(3):153–9.
